von Gunten, Stephan; Simon, Hans-Uwe (2008). Natural anti-Siglec autoantibodies mediate potential immunoregulatory mechanisms: implications for the clinical use of intravenous immunoglobulins (IVIg). Autoimmunity reviews, 7(6), pp. 453-6. Amsterdam: Elsevier 10.1016/j.autrev.2008.03.015
Full text not available from this repository. (Request a copy)Human intravenous immunoglobulins (IVIg) contain natural autoantibodies against the inhibitory lectin-receptors Siglec-8 and Siglec-9. These two members of the Siglec family are known to mediate both inhibitory and death signals. Here, we discuss recent findings regarding the cytotoxic effects of natural anti-Siglec autoantibodies on both neutrophils and eosinophils, and present the concept of a novel regulatory mechanism exhibiting anti-inflammatory properties. Consequently, IVIg may amplify this regulatory pathway by increasing the concentration of natural anti-Siglec autoantibodies in blood and tissues.
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Pharmacology |
UniBE Contributor: |
Simon, Hans-Uwe |
ISSN: |
1568-9972 |
ISBN: |
18558361 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 15:03 |
Last Modified: |
05 Dec 2022 14:19 |
Publisher DOI: |
10.1016/j.autrev.2008.03.015 |
PubMed ID: |
18558361 |
Web of Science ID: |
000257590300009 |
URI: |
https://boris.unibe.ch/id/eprint/27538 (FactScience: 108762) |
Actions (login required)
 |
Edit item |